Diffuselargeb-celllymphoma相关论文
SAF-248,a novel PI3Kδ-selective inhibitor,potently suppresses the growth of diffuse large B-cell lym
PI3Kδ is expressed predominately in leukocytes and overexpressed in B-cell-related malignances.PI3Kδ has been validate......
Prognostic Nomogram and predictive factors in refractory or relapsed diffuse large B-cell lymphoma p
...
C-reactive protein-to-albumin ratio is an independent poor prognosis and improving NCCN-IPI score in
...
Objective International prognostic index(IPI)has been widely used for risk stratification in patients with aggressive NH......
The photosensitizer Verteporfin exerted anti-tumor effect in diffuse large B-cell lymphoma via disru
Objective Hippo-YAP signaling,an evolutionarily conserved growth control pathway,has emerged as a crucial player in the ......
...
An evaluation of different staging systems and their prognostic analyses of 365 primary gastrointest
...
Objective Background: Ubiquitin-ligase Fbw7 can induce degradation of many proto-oncogenes and suppress tumor.This aim o......
CDK6 Overexpression Resulted from MicroRNA-320d Downregulation Promotes Cell Proliferation in Diffus
Objective Objects: to investigate the role of CDK6 and microRNA-320d in diffuse large B cell lymphoma(DLBCL)and the rela......
Lymphocyte transformation from autoimmune haematological diseases to lymphoproliferative syndrome an
Autoimmune diseases (ADs) have close relationship with the onset of malignant lymphoma.The recent research focuses on AD......
Ibrutinib inhibits microenvironment-mediated drug resistance in Diffuse large B-cell lymphoma in vit
Ibrutinib, an irreversible Brutons tyrosine kinase (BTK) inhibitor, has induced significant clinical responses in B-cell......
Identifying important biomarkers that are predictive for cancer patients prognosis is key in gaining better insights int......
...
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in patients with stage I d
The role of rituximab in combination with CHOP-like chemotherapy regimens in patients with stage I diffuse large-B c......
目的：评估治疗前18氟-氟代脱氧葡萄糖-正电子发射计算机断层显像（18F-FDG-PET）/CT的最大标化摄取值（SUVmax）对弥漫大B细胞淋巴瘤（DLBCL）预......
目的探讨老年弥漫大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)的临床病理学特征和疗效。方法对2003年1月-2012年12月我院......
High-dose Chemotherapy Combined with Autologous Hematopoietic Stem Cell Transplantation as Frontline
The role of autologous hematopoietic stem cell transplantation(auto-HSCT)following high-dose chemotherapy has been valid......
目的探讨人粒细胞-巨噬细胞集落刺激因子(rhGM-CSF)联合R-CHOP方案治疗弥漫大B细胞淋巴瘤的临床疗效。方法选取2014年1月至2015年1......
弥漫大B细胞淋巴瘤（ DLBCL）是一种异质性很强的病症，尤其是结外 DLBCL，其临床表现及发病机制具有复杂性、多样性等显著特点。近年来，对......
【摘要】目的观察美罗华(利妥昔单抗,Rituximab)联合COTP方案化疗治疗方案治疗老年弥漫大B细胞性淋巴瘤的临床疗效和毒副反应。方......
Diffuse large B-cell lymphoma(DLBCL)is the most common type of non-Hodgkin lymphoma,char-acterized by high heterogeneity......
目的 探讨弥漫大B细胞性淋巴瘤(DLBCL) 临床病理特点与利妥昔单抗疗效之间的关系.方法 回顾性分析69例采用利妥昔单抗联合化疗治疗......
